MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study. (Q33390410)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

22 January 2020

MDMA

0 references

title

MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

22 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

22 January 2020

Edward Ogden

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

22 January 2020

Con Stough

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Andrew C Parrott

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

22 January 2020

Amy Gibbs

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

22 January 2020

Katherine Owens

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

22 January 2020

Phil Swann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

22 January 2020

Rebecca King

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

22 January 2020

publication date

12 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

22 January 2020

number of pages

10

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

22 January 2020

volume

215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

22 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

527-536

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

A review of the acute subjective effects of MDMA/ecstasy

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Effects of MDMA on sociability and neural response to social threat and social reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Effects of repeated oral methamphetamine administration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

A review of the clinical pharmacology of methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Subjective reports of the effects of MDMA in a clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Methamphetamine self-administration by humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Acute physiological and behavioral effects of intranasal methamphetamine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Plasma drug concentrations and physiological measures in 'dance party' participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Gender differences in the subjective effects of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Biological basis of sex differences in drug abuse: preclinical and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

"Partying" hard: party style, motives for and effects of MDMA use at rave parties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Chronic MDMA (ecstasy) use, cognition and mood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Human pharmacology of the methamphetamine stereoisomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Executive working memory deficits in abstinent ecstasy/MDMA users: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

The relationship between performance on the standardised field sobriety tests, driving performance and the level of Delta9-tetrahydrocannabinol (THC) in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Individual differences in stress and arousal during cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Does cigarette smoking cause stress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Hair MDMA samples are consistent with reported ecstasy use: findings from a study investigating effects of ecstasy on mood and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

The subjective effects of MDMA and mCPP in moderate MDMA users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Development and validation of brief measures of positive and negative affect: The PANAS scales

21 January 2018

2 references

https://api.crossref.org/works/10.1007/S00213-011-2184-9

21 January 2018

12 December 2020

Personality and the subjective effects of acute amphetamine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

It's a rave new world: estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2184-9

Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.

21 January 2018

1 reference

PubMed

12 December 2020

Ecstasy use in Australia: patterns of use and associated harm

1 reference

PubMed

12 December 2020

The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance.

1 reference

PubMed

12 December 2020

10.1007/S00213-011-2184-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318566 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

22 January 2020

1033557268

0 references

1 reference